Sofinnova Investments, Inc.
69 holdingsFiling period: 2026-03-31Current AUM: $2.86Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | 1.55M | $310.0M | $415.1M | 14.50% | -- | 2026-03-31 |
| 2 | IWM | iShares TR | 600.0K | $148.8M | $174.7M | 6.10% | -- | 2026-03-31 |
| 3 | UTHR | United Therapeutics Corp | 240.4K | $142.5M | $124.4M | 4.35% | +82.7K | 2026-03-31 |
| 4 | XBI | SPDR Series Trust | 1.05M | $134.1M | $154.4M | 5.39% | -- | 2026-03-31 |
| 5 | BMY | Bristol-Myers Squibb Co | 1.99M | $120.6M | $129.9M | 4.54% | +475.7K | 2026-03-31 |
| 6 | — | Jazz Pharmaceuticals PLC | 598.3K | $113.1M | $113.1M | 3.95% | -361,533 | 2026-03-31 |
| 7 | VERA | Vera Therapeutics Inc | 2.79M | $112.4M | $89.7M | 3.13% | -- | 2026-03-31 |
| 8 | — | AstraZeneca PLC | 456.0K | $89.9M | $89.9M | 3.14% | -- | 2026-03-31 |
| 9 | QQQ | Invesco QQQ TR | 150.0K | $86.6M | $103.2M | 3.61% | -- | 2026-03-31 |
| 10 | COGT | Cogent Biosciences Inc | 2.11M | $81.3M | $82.3M | 2.87% | +139.9K | 2026-03-31 |
| 11 | IBB | iShares TR | 475.0K | $80.2M | $88.5M | 3.09% | -- | 2026-03-31 |
| 12 | CELC | Celcuity Inc | 666.2K | $76.0M | $57.5M | 2.01% | +366.8K | 2026-03-31 |
| 13 | RARE | Ultragenyx Pharmaceutical Inc | 3.50M | $73.2M | $87.1M | 3.04% | +3.41M | 2026-03-31 |
| 14 | AXSM | Axsome Therapeutics Inc. | 412.7K | $69.8M | $90.0M | 3.14% | +400.5K | 2026-03-31 |
| 15 | RAPP | Rapport Therapeutics Inc | 1.90M | $59.6M | $78.0M | 2.73% | -- | 2026-03-31 |
| 16 | INSM | Insmed Inc | 346.1K | $56.6M | $34.1M | 1.19% | +189.3K | 2026-03-31 |
| 17 | — | Alcon AG | 730.0K | $55.0M | $55.0M | 1.92% | +397.5K | 2026-03-31 |
| 18 | SUPN | Supernus Pharmaceuticals | 954.3K | $49.3M | $42.6M | 1.49% | +401.2K | 2026-03-31 |
| 19 | BMRN | BioMarin Pharmaceutical Inc | 782.0K | $44.2M | $46.9M | 1.64% | +84.8K | 2026-03-31 |
| 20 | BIIB | Biogen Inc | 229.5K | $42.1M | $46.6M | 1.63% | -- | 2026-03-31 |
| 21 | BIOA | BioAge Labs Inc | 2.29M | $40.1M | $20.7M | 0.72% | -- | 2026-03-31 |
| 22 | AVBP | Arrivent BioPharma Inc | 1.70M | $39.1M | $50.6M | 1.77% | -- | 2026-03-31 |
| 23 | RYTM | Rhythm Pharmaceuticals Inc | 450.1K | $39.1M | $44.7M | 1.56% | +178.7K | 2026-03-31 |
| 24 | IDYA | IDEAYA Biosciences Inc | 1.13M | $37.7M | $40.2M | 1.40% | +246.7K | 2026-03-31 |
| 25 | IMNM | Immunome Inc | 1.70M | $37.2M | $38.7M | 1.35% | +83.4K | 2026-03-31 |
← Scroll →
Page 1 of 3